AzTrials
AzTrials

AutismCHIMENCT06016621

Autism - Children's Improvisational Music Therapy Evaluation

A study testing Improvisational Music Therapy in people with Autism, run by Prof Simon Baron-Cohen at 2 sites in United Kingdom.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to evaluate the effectiveness of individual sessions of improvisational music therapy for autistic children aged 7 - 11. Researchers will compare the impact of adding improvisational music therapy to usual care alone for autistic children over a 12-week period. Read more about this study

Who is it for?
Ages 7 to 11 years
Conditions the study is for
Autism
What is being tested?
Improvisational Music Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
240 participants
Where
2 sitesUnited Kingdom
Study dates
13 Nov 2023to Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 11 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Aged 7 to 11 years.
  • A clinical diagnosis of autism made by a qualified professional according to the International Classification of Diseases (ICD) 10th Revision criteria. Confirmed by a copy of the clinical report detailing the diagnosis (if available) or verified verbally by the child's parents.
  • Parents/guardians must give informed consent for their children to be enrolled in the trial.
  • Parents/guardians must be willing for the music therapy sessions and BOSCC assessments to be video recorded for monitoring and research purpose
  • Participants must be willing to attend two music therapy sessions per week for the duration of the trial.
  • Non-verbal children may be included

Who cannot join

  • Received regular individual music therapy in the preceding year as this would be likely to have a strong influence on the course of therapy.
  • Severe hearing deficit as this would alter the aim, course, and implementation of therapy.
  • Caregivers that are unable to attend for the psychological assessments with their child.
  • Caregivers without a basic understanding of English.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Simon Baron-Cohen, Professor contact

01223 465215

sb205@cam.ac.uk

Artur Jaschke, PhD contact

aj723@cam.ac.uk

United Kingdom2 sites, 2 recruiting
  • Anglia Ruskin University

    Cambridge, CB1 1PT

    Jonathan Pool, PhD

    Recruiting
  • Autism Research Centre

    Cambridge, CB2 8AH

    Artur Jaschke, PhD

    Recruiting

Other trials in United Kingdom

About this study

Official title: A Randomised Controlled Trial on the Effectiveness of Improvisational Music Therapy for Autistic Children Aged 7 - 11 [Autism-CHIME Trial].

The goal of this clinical trial is to evaluate the effectiveness of individual sessions of improvisational music therapy for autistic children aged 7 - 11.

Researchers will compare the impact of adding improvisational music therapy to usual care alone for autistic children over a 12-week period.

Read more

Participants will be randomly assigned to one of the following two conditions: the Improvisational Music Therapy (intervention) Group or the support as usual (control) Group.

The aim is to achieve seven overarching objectives:

  1. To determine whether 12 weeks of individual sessions of improvisational music therapy in addition to support as usual is superior to support as usual alone in improving social communication in autistic children.
  2. To examine whether 12 weeks of individual sessions of improvisational music therapy in addition to support as usual is superior to support as usual alone in improving communication skills in autistic children.
  3. To examine whether 12 weeks of individual sessions of improvisational music therapy in addition to support as usual is superior to support as usual alone in reducing psychosocial problems in autistic children.
  4. To examine whether 12 weeks of individual sessions of improvisational music therapy in addition to support as usual is superior to support as usual alone in improving wellbeing of autistic children.
  5. To examine whether 12 weeks of individual sessions of improvisational music therapy in addition to support as usual is superior to support as usual alone in improving adaptive functioning in autistic children.
  6. To examine whether 12 weeks of individual sessions of improvisational music therapy in addition to support as usual is superior to support as usual alone in improving anxiety in autistic children.
  7. To examine whether the therapeutic relationship predicts the development of social, communication and language skills among autistic children.
Read the detailed description

Co-Chief Investigators Professor Simon Baron-Cohen Dr Carrie Allison Dr David M. Greenberg Dr. Jonathan Pool

Co-Investigators Dr Artur Jaschke

Advisor Emeritus Professor Helen Odell-Miller Dr. Claire Howlin

The Autism-CHIME trial is designed as a rigorous Randomised Controlled Trial (RCT) of individual sessions of improvisational music therapy with autistic children. The trial will be conducted in mainstream and special schools located in Cambridgeshire, Peterborough, London, and the South and East of England. The number of schools involved will depend on the number of eligible children willing to participate, with a minimum of 5-10 children per school.

Enrolled participants will undergo 1:1 block randomisation, to either support as usual plus improvisational music therapy sessions (intervention arm) or support as usual (control arm). Randomisation will occur after the baseline assessments have been completed. Participants will be stratified based on the version of the Brief Observation of Social Communication Change (BOSCC) that they are allocated (primary outcome measure): (1) Minimally Verbal, (2) Phrase Speakers, or (3) Fluent Speakers, so that there are equal numbers in each group, and that the control group and experimental group are balanced.

Data will be collected at different time points during the trial:

The first data collection point (T1) will be collected prior to randomisation (to establish eligibility to participate and assess baseline functioning), and at the primary endpoint T2 (13 weeks after randomisation; end of intervention) and the secondary endpoint T3 will be 39 weeks post-randomisation (i.e. 6 months after the end of music therapy).

The trial will finish after the final follow-up data collection from the participants is completed.

Conditions
Autism
Being tested
Improvisational Music Therapy
Keywords
Randomised Controlled Trial, Improvisational music therapy, Autism, Children, Social communication, Social cognition
Medical subject headings
Autistic Disorder, Communication

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Improvisational Music TherapyBehavioural

    The therapist engages with the child by playing and sharing musical instruments, and/or sings while being attuned to the child's behaviour and expression. Various improvisational techniques are employed to engage the child. There are opportunities for pulse, rhythmic, dynamic or melodic patterns, and timbre to be mirrored, reinforced, or complemented, which allows for moments of synchronization between the therapist and the child, giving the child's musical expressions a pragmatic meaning within this context. The therapist may also gently provoke the child by violating expectations or patterns that have been jointly developed in order to elicit specific social communication behaviours. Further, there are opportunities for the child to develop and enhance social communication skills such as joint attention, sharing affect, reciprocity, shared history, scaffolding, imitation and turn-taking. These have been shown to develop social competency and also resilience.

Study groups in NCT06016621
Study groupRoleWhat they receive
Support as usual control GroupNo interventionParticipants allocated to 'support as usual' will receive routine support from their general practitioners (GPs), mental health and education/allied health professionals. Support as usual is defined as normal practice for each school in addition to the usual support from the specialist teaching teams for autism in the area, or any other additional therapies intended to support communication skills or wellbeing for autistic children. They will not receive the individual music therapy intervention or any extra support services from the research team. Any concomitant treatment or therapeutic interventions that participating children might receive will be recorded during assessment sessions before randomisation, and following the primary endpoint, specifying the kind and amount or frequency of intervention.
Improvisational Music TherapyExperimentalParticipating children randomised to the Improvisational Music Therapy (intervention) Group will receive 30-minute individual music therapy sessions two times per week over a 12-week period. These will be delivered by academically trained Health and Care Professions Council (HCPC)-registered music therapists in the United Kingdom (master's level or equivalent) with clinical experience of working with autistic children. Each child in the intervention arm will receive 24 sessions of music therapy over a 12-week period. A music therapy training manual will be used to guide music therapists.
Receives: Behavioral: Improvisational Music Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Absolute change of the total score of the Brief Observation of Social Communication Change (BOSCC). One of three versions of the BOSCC will be used depending on the child's level of verbal communication.

    The BOSCC consists of specific items that were developed to identify changes in social-communication behaviours over relatively short periods of time by quantifying subtleties in both the frequency and the quality of specific behaviours. There are three forms of the BOSCC: one for individuals who are minimally verbal (MV), one for those with phrase speech/young fluent speakers (PS/YF up to age 6 - 8) and one for fluent speakers (F1/F2 with two sets of materials, one for children and one for adolescents and adults). Scores are based on the observation of social communicative behaviour during naturalistic interactions between a child and an adult.

    Measured: Baseline and at the end of intervention (13 weeks after randomisation).

Secondary outcomes (8)
  1. Absolute change of the total score of the BOSCC.

    The BOSCC consists of specific items that were developed to identify changes in social-communication behaviours.

    Measured: Baseline and 39 weeks after randomisation.

  2. Absolute change of the total score of the Children's Communication Checklist-2 to test improvement in communication skills.

    Measure designed to assess the communication skills of children 4 to 16. It includes two domains: Language (Speech, Syntax, Semantics, Coherence) and Pragmatics (Initiation, Scripted Language, Context, Nonverbal Communication, Social Relations, Interests).

    Measured: Baseline, 13 and 39 weeks after randomisation.

  3. Absolute change of the total score of the Strengths and Difficulties Questionnaire to test improvement in psychosocial difficulties

    Questionnaire of behavioural and emotional difficulties suitable for children aged 3-16 years old. It addresses different dimensions: emotional problems, conduct problems, hyperactivity/inattention problems, peer problems and prosocial behaviour.

    Measured: Baseline, 13 and 39 weeks after randomisation.

  4. Absolute change of the total score of the Young Child Outcome Rating Scale (YCORS) as a measure of wellbeing.

    Engaging young children regarding their assessment of how they are doing using child friendly language (faces).

    Measured: Baseline, 13 and 39 weeks after randomisation.

  5. Absolute change of the total score of the Vineland-3 Domain level parent/caregiver form to test improvement in adaptive functioning.

    Measure of adaptive functioning including Communication domain, Daily living skills domain and Socialization domain.

    Measured: Baseline, 13 and 39 weeks after randomisation.

  6. Absolute change of the total score of the Parent-Rated Anxiety Scale (PRAS) for Youth with Autism Spectrum Disorder (ASD) as a measure of anxiety.

    The PRAS-ASD is a 25-item, parent-reported measure of anxiety symptoms in youth with ASD (age 5-17 years).

    Measured: Baseline, 13 and 39 weeks after randomisation.

  7. Association between the therapeutic relationship and the development of social, communication and language skills.

    The therapeutic relationship will be measured using the Assessment of the Quality of Relationship (AQR), based on video recordings of the first and last of music therapy to evaluate the association between the therapeutic relationship and the development of social, communication and language skills in children allocated to the music therapy intervention.

    Measured: Weeks 1 and 12

  8. Absolute change of the total score of the Music Therapy Communication and Social Interaction Scale (MTCSI) (or Music Engagement Scale, MES) based on video recordings.

    Measured based on video recordings of the first and last weeks of music therapy in all of the children allocated to the music therapy intervention) to evaluate communicative and socially interactive responses that are elicited during music therapy sessions.

    Measured: Weeks 1 and 12.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Aug 2023
  2. Study start13 Nov 2023
  3. Primary completionDec 2025 (estimated)
  4. Study completionDec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Assessor-blind, multi-centre, pragmatic, two-arm, randomised controlled trial in which participants will be randomly allocated to either: 1. Twice-weekly 30 minute-sessions of one to one improvisational music therapy over 12 weeks, in addition to support as usual. 2. Support as usual control group.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
240 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06016621
Sponsor's protocol ID
PRE.2022.077
Other IDs
ETH2223-3184
Acronym
CHIME
Status last verified
Mar 2025
First submitted
19 Aug 2023
Last updated
25 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Levitin, D. J. This is your brain on music: The science of a human obsession. vi, 314 (Dutton/Penguin Books, 2006).

  • Savage PE, Loui P, Tarr B, Schachner A, Glowacki L, Mithen S, Fitch WT. Music as a coevolved system for social bonding. Behav Brain Sci. 2020 Aug 20;44:e59. doi: 10.1017/S0140525X20000333.

    PubMed 32814608
  • Sharda M, Tuerk C, Chowdhury R, Jamey K, Foster N, Custo-Blanch M, Tan M, Nadig A, Hyde K. Music improves social communication and auditory-motor connectivity in children with autism. Transl Psychiatry. 2018 Oct 23;8(1):231. doi: 10.1038/s41398-018-0287-3.

    PubMed 30352997
  • American Music Therapy Association (AMTA). https://www.musictherapy.org/.

  • Diagnostic and statistical manual of mental disorders: DSM-5TM, 5th ed. xliv, 947 (American Psychiatric Publishing, Inc., 2013). doi:10.1176/appi.books.9780890425596.

  • Kanner L. Autistic disturbances of affective contact. Acta Paedopsychiatr. 1968;35(4):100-36. No abstract available.

    PubMed 4880460
  • Stegemann T, Geretsegger M, Phan Quoc E, Riedl H, Smetana M. Music Therapy and Other Music-Based Interventions in Pediatric Health Care: An Overview. Medicines (Basel). 2019 Feb 14;6(1):25. doi: 10.3390/medicines6010025.

    PubMed 30769834
  • Lim HA, Draper E. The effects of music therapy incorporated with applied behavior analysis verbal behavior approach for children with autism spectrum disorders. J Music Ther. 2011 Winter;48(4):532-50. doi: 10.1093/jmt/48.4.532.

    PubMed 22506303
  • Lim HA. Effect of "developmental speech and language training through music" on speech production in children with autism spectrum disorders. J Music Ther. 2010 Spring;47(1):2-26. doi: 10.1093/jmt/47.1.2.

    PubMed 20635521
  • Carpente, J. A. Investigating the Effectiveness of a Developmental, Individual Difference, Relationship-Based (DIR) Improvisational Music Therapy Program on Social Communication for Children with Autism Spectrum Disorder. Music Therapy Perspectives 35, 160-174 (2017).

  • Thompson GA, McFerran KS, Gold C. Family-centred music therapy to promote social engagement in young children with severe autism spectrum disorder: a randomized controlled study. Child Care Health Dev. 2014 Nov;40(6):840-52. doi: 10.1111/cch.12121. Epub 2013 Nov 22.

    PubMed 24261547
  • Walworth DD. The use of music therapy within the SCERTS model for children with Autism Spectrum Disorder. J Music Ther. 2007 Spring;44(1):2-22. doi: 10.1093/jmt/44.1.2.

    PubMed 17419661
  • Walworth DD, Register D, Engel JN. Using the SCERTS model assessment tool to identify music therapy goals for clients with autism spectrum disorder. J Music Ther. 2009 Fall;46(3):204-16. doi: 10.1093/jmt/46.3.204.

    PubMed 19757876
  • LaGasse AB. Effects of a music therapy group intervention on enhancing social skills in children with autism. J Music Ther. 2014 Fall;51(3):250-75. doi: 10.1093/jmt/thu012. Epub 2014 Jul 22.

    PubMed 25053766
  • Kim J, Wigram T, Gold C. The effects of improvisational music therapy on joint attention behaviors in autistic children: a randomized controlled study. J Autism Dev Disord. 2008 Oct;38(9):1758-66. doi: 10.1007/s10803-008-0566-6. Epub 2008 Jul 1.

    PubMed 18592368

Questions about this trial

What is this clinical trial studying?

A study testing Improvisational Music Therapy in people with Autism, run by Prof Simon Baron-Cohen at 2 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 25 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Simon Baron-Cohen, Professor (01223 465215, sb205@cam.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Absolute change of the total score of the Brief Observation of Social Communication Change (BOSCC). One of three versions of the BOSCC will be used depending on the child's level of verbal communication. (time frame: Baseline and at the end of intervention (13 weeks after randomisation).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06016621, which also lists 54 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in